Summary of Purpose
The purpose of the study is to collect additional information of Xarelto treatment in routine clinical practice. Patients affected by atrial fibrillation and who will get Xarelto as a prophylactic treatment against stroke and systemic embolism (Stroke Prevention in Atrial Fibrillation) will be observed.Read More →
The following dates are available for this trial. Trial information last updated on 12 April 2018.
|11 Sep 2017||14 Sep 2017||30 Sep 2019||31 Dec 2019||1 Apr 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Bayer Clinical Trials Contact
- For Trial Location Information (Phone Menu Options '3' or '4')